title: Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism.
abstract: The glycolytic response of hypoxic cells is primarily mediated by the hypoxia inducible factor alpha (HIF-1α) but even in the presence of abundant oxygen tumours typically show high rates of glycolysis. Higher levels of HIF-1α in tumours are associated with a poorer prognosis and up-regulation of markers of epithelial mesenchymal transition (EMT) due to HIF-1α actions. We have recently shown that EMT occurs within the CD44(high) cancer stem cell (CSC) fraction and that epithelial and EMT CSCs are distinguished by high and low ESA expression, respectively. We here show that hypoxia induces a marked shift of the CSC fraction towards EMT leading to altered cell morphology, an increased proportion of CD44(high)/ESA(low) cells, patterns of gene expression typical of EMT, and enhanced sphere-forming ability. The size of EMT fractions returned to control levels in normoxia indicating a reversible process. Surprisingly, however, even under normoxic conditions a fraction of EMT CSCs was present and maintained high levels of HIF-1α, apparently due to actions of cytokines such as TNFα. Functionally, this EMT CSC fraction showed decreased mitochondrial mass and membrane potential, consumed far less oxygen per cell, and produced markedly reduced levels of reactive oxygen species (ROS). These differences in the patterns of oxygen metabolism of sub-fractions of tumour cells provide an explanation for the general therapeutic resistance of CSCs and for the even greater resistance of EMT CSCs. They also identify potential mechanisms for manipulation of CSCs.
authors: Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
authors: Luke
authors: L
authors: Gammon
authors: Adrian
authors: A
authors: Biddle
authors: Hannah K
authors: HK
authors: Heywood
authors: Anne C
authors: AC
authors: Johannessen
authors: Ian C
authors: IC
authors: Mackenzie
mesh_terms: D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D058750:Epithelial-Mesenchymal Transition; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism / Q000473:pathology; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000378:metabolism* / Q000473:pathology; D010100:Oxygen / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D018960:Hyaluronan Receptors; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D017382:Reactive Oxygen Species; D010100:Oxygen
references: Cancer Res. 1999 Nov 15;59(22):5830-5
references: 10582706
references: BMC Cancer. 2010 Apr 28;10:166
references: 20426848
references: PLoS One. 2013;8(2):e56664
references: 23431386
references: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8
references: 17210912
references: Curr Opin Cell Biol. 2003 Dec;15(6):740-6
references: 14644200
references: PLoS One. 2009;4(3):e4849
references: 19287496
references: J Cell Biol. 2007 Jul 30;178(3):425-36
references: 17664334
references: Cell Metab. 2006 Mar;3(3):187-97
references: 16517406
references: FASEB J. 2003 Mar;17(3):503-5
references: 12514119
references: Nat Rev Cancer. 2005 Sep;5(9):744-9
references: 16148886
references: Radiother Oncol. 1999 Nov;53(2):113-7
references: 10665787
references: J Gen Physiol. 1927 Mar 7;8(6):519-30
references: 19872213
references: J Pathol. 1990 Mar;160(3):259-69
references: 1692339
references: Cell. 2008 May 16;133(4):704-15
references: 18485877
references: Int J Cancer. 2007 Jan 15;120(2):268-77
references: 17066447
references: J Oral Pathol Med. 2007 Nov;36(10):594-603
references: 17944752
references: Dev Cell. 2007 Jun;12(6):845-6
references: 17543856
references: J Cell Physiol. 2006 Feb;206(2):402-10
references: 16155906
references: Cell. 2009 Aug 21;138(4):645-659
references: 19682730
references: Mol Cancer Ther. 2008 Jul;7(7):1961-73
references: 18645006
references: Cancer Res. 2011 Aug 1;71(15):5317-26
references: 21685475
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references: 12629218
references: Cancer Sci. 2005 Jul;96(7):394-402
references: 16053510
references: Br J Cancer. 2008 Jun 17;98(12):1975-84
references: 18542064
references: Nat Cell Biol. 2010 Oct;12(10):982-92
references: 20818389
references: Physiology (Bethesda). 2004 Aug;19:176-82
references: 15304631
references: Biochem J. 2008 Jun 15;412(3):477-84
references: 18393939
references: Nature. 2009 Apr 9;458(7239):780-3
references: 19194462
references: Cancer Res. 2006 Oct 1;66(19):9339-44
references: 16990346
references: Breast Cancer Res. 2010;12(6):R94
references: 21067584
references: J Biol Chem. 2008 Aug 15;283(33):22700-8
references: 18541534
references: PLoS One. 2009 Dec 31;4(12):e8531
references: 20046830
references: PLoS One. 2011;6(10):e26064
references: 22016813
references: Cancer Cell. 2007 May;11(5):407-20
references: 17482131
references: Science. 1956 Aug 10;124(3215):269-70
references: 13351639
references: Cell Metab. 2006 Mar;3(3):177-85
references: 16517405
references: Nat Cell Biol. 2008 Mar;10(3):295-305
references: 18297062
references: Genes Dev. 2003 May 15;17(10):1253-70
references: 12756227
references: Proc Natl Acad Sci U S A. 1997 May 27;94(11):5667-72
references: 9159130
references: PLoS One. 2011 Jan 27;6(1):e16466
references: 21304586